Dr Jessica Roydhouse is a Senior Research Fellow at the Menzies Institute for Medical Research and the Academic Lead for the Prostate Cancer Outcomes Registry - Tasmania.

Her research focuses on patient-reported outcomes, proxy reporting, cancer clinical trials and treatment tolerability.

Jessica is the Editor-in-Chief of Quality of Life Research and the Chair of the International Society of Quality of Life Research Australia and New Zealand Special Interest Group. Formerly, Jessica was an Associate Editor for the Journal of Patient-Reported Outcomes and Health and Quality of Life Outcomes, and she was a member of the GP5 Working Group of the US National Cancer Institute Cancer Treatment Tolerability Consortium as well as a Chair of the Professional Society for Health Economics and Outcomes Research (ISPOR) Patient-Centered Special Interest Group.

Jessica is the recipient of the International Society of Quality of Life Research Donna Lamping Emerging Leader Award (2021) and the ISPOR Bernie O'Brien New Investigator Award (2023).